Related Experiment Video
Updated: Dec 25, 2025
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Effects of Indoor Air Purifiers on Children with Asthma
Ga Hee Lee1, Jeong Hee Kim1,2, Sungroul Kim3,4
1Departmenet of Pediatrics, School of Medicine, Inha University, Incheon, Korea.
Insights
Air purifiers significantly reduced particulate matter (PM2.5) levels indoors, leading to a decrease in asthma medication use for children. This study highlights the benefits of air purifiers for managing childhood asthma effectively.
Area of Science:
- Environmental Health
- Pediatric Respiratory Medicine
- Clinical Allergy and Immunology
Background:
- Indoor air quality significantly impacts respiratory health, particularly in children with asthma.
- Particulate matter (PM2.5) is a major trigger for asthma exacerbations.
- Effective asthma management requires addressing environmental triggers like indoor air pollutants.
Purpose of the Study:
- To investigate the efficacy of air purifiers in reducing indoor air pollutants.
- To assess the impact of air purifiers on asthma control in pediatric populations.
- To evaluate changes in asthma severity, lung function, and inflammatory markers.
Main Methods:
- A randomized crossover trial involving 30 elementary school students with asthma.
- Comparison of daily air purifier filter use versus a placebo (filter off).
- Primary endpoints included indoor air quality (PM2.5, CO₂), asthma symptom/medication scores, lung function (peak expiratory flow), and fractional exhaled nitric oxide.
Main Results:
- Air purifier use significantly reduced mean PM2.5 concentrations from 17.0 μg/m³ to 9.26 μg/m³.
- A statistically significant decrease in asthma medication frequency was observed during air purifier operation.
- Bacterial richness in indoor air was markedly lower when air purifiers were in use.
Conclusions:
- Air purifiers are effective in reducing indoor PM2.5 levels.
- The use of air purifiers can decrease the medication burden for children with asthma.
- Air purification represents a viable strategy for improving asthma control in pediatric patients.
Purpose:
To evaluate the effects of air purifiers on the concentrations of indoor air pollutants and on asthma control in children.
Materials And Methods:
In this randomized crossover trial, daily use of an air purifier filter was compared with a matched placebo with the filter off. Thirty elementary school students who had asthma were enrolled and randomly allocated to one of two groups. The primary endpoints were changes in indoor air quality, asthma severity, lung function, airway inflammatory, urine microbiome, and phthalate after the installation of air purifiers. PM2.5 and CO₂ were measured as indoor air pollutants. Asthma severity was assessed in terms of both symptom and medication scores acquired using a daily questionnaire. The higher the score, the better the symptom or the less frequent the use of medication. Peak expiratory flow rate and fractional exhaled nitric oxide were also measured.
Results:
The mean age of the enrolled patients was 9.2±1.98 years. The mean concentration of PM2.5 was 17.0 μg/m³ in the filter-off condition, but significantly lower at 9.26 μg/m³ in the filter-on condition. Medication scores were 6.9 for the filter-off and 7.12 for the filter-on conditions, reflecting a statistically significant decrease in the frequency of medications used during air purifier operation. Bacterial richness, as determined using the Chao 1 index, was markedly lower in the filter-on than the filter-off condition.
Conclusion:
This study suggests that air purifiers benefit medication burden in children with asthma by reducing PM2.5 levels.
Related Concept Videos
01:29Asthma-I: Introduction
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...